Advertisement

Topics

AiCuris Announces Final Patient Treated In Clinical Phase II Trial (LipP 1) With Topical Pritelivir For The Treatment Of Recurrent Labial Herpes

20:00 EDT 23 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: AiCuris Announces Final Patient Treated In Clinical Phase II Trial (LipP 1) With Topical Pritelivir For The Treatment Of Recurrent Labial Herpes

NEXT ARTICLE

More From BioPortfolio on "AiCuris Announces Final Patient Treated In Clinical Phase II Trial (LipP 1) With Topical Pritelivir For The Treatment Of Recurrent Labial Herpes"

Advertisement
Quick Search
Advertisement
Advertisement